Efficacy of a 585 nm PDL for the Treatment of Dermatosis Papulosa Nigra, and Compare it to Therapy With Curettage and Electrodesiccation.
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
The physician will assess percent clearance of all treated lesions and the control lesion, evidence of hypo or hyper pigmentation, scar, keloid, and texture irregularities.
6 to 12 weeks
Daniel Eisen, M.D.
University of California, Davis
United States: Institutional Review Board
|University of California, Davis Department of Dermatology||Sacramento, California 95816|